What we know
Strain
Lab-confirmed Bundibugyo ebolavirus (BDBV). This is the third recognised BDBV outbreak; prior ones were Uganda 2007-2008 (149 cases, 37 deaths) and DRC 2012 Orientale Province (57 cases, 29 deaths).
Counts
DRC has reported 11,432 confirmed Bundibugyo cases and 5,593 confirmed deaths as of 15 November, a case-fatality rate of 48.9%, according to INSP situation report N°185. With Uganda's final 20 cases and 2 deaths and Kenya's 9 cases and 2 deaths, the headline is 11,461 cases and 5,597 deaths. DRC confirmed 442 cases in the week to 15 November, about 63 a day, within the 400 to 500 a week WHO describes, and two thirds of confirmed deaths occur in the community.
More on counts (6 paragraphs)Show less
The headline tally counts confirmed cases in DRC, Uganda and Kenya: 11,461 cases and 5,597 deaths. DRC stands at 11,432 confirmed cases and 5,593 confirmed deaths as of 15 November, a case-fatality rate of 48.9%; Uganda's final count is 20 cases and 2 deaths, and Kenya has 9 cases and 2 deaths, for a combined crude case-fatality rate of 48.8%. Nigeria's imported case, like the exported and evacuated cases in Europe, stays outside it. SitRep N°185, for 15 November, went up on INSP's site on 17 November. Its province and zone tables add up exactly to the national figures, with one flag: Tshopo's Lubunga zone shows 2 deaths against 1 case, marked as being harmonised, and the care section reports that a confirmed patient transferred from Lubunga died five minutes after arriving. The same section mentions an infant in Nord-Ubangi who turned positive, while the province's table records no new case. Earlier, N°182 listed a new case in Nia-Nia and N°184 two in Butembo that the cumulative columns never carried. EbolaIntel's markers follow the cumulative columns. The 493 Ituri deaths not yet assigned to a zone are still in the table.
Day by day: N°185 reports 56 cases and 25 deaths on 15 November, 6.7% fewer cases than the day before: 29 in North Kivu, 23 in Ituri, 3 in Haut-Uele and 1 in Tshopo. Eighteen of the deaths occurred in the community and seven in treatment centres. Laboratories tested 435 samples, 12.9% of them positive. Beni added 14 cases, Mandima 10, Bunia 8 and Oicha 6, and no new zone was affected. The four days before, covered by N°181 to N°184, added 262 cases and 135 deaths, 83, 57, 62 and 60 cases a day, 75 of the deaths in the community; Beni added 41 cases, Mandima 33, Mangala 27 and Bunia 21, Watsa in Haut-Uele became the 68th zone on 11 November, and Tshopo reported nine cases from 12 to 14 November. The week to 15 November counts 442 cases and 239 deaths.
The combined case-fatality rate is 48.8%, and the DRC-only ratio 48.9%. Contact follow-up reached 85.1% on 15 November (30,243 of 35,559 contacts seen), up from 83.1% the day before but still below the 95% the SitRep sets: Nord-Ubangi 99.0%, Ituri 93.1%, Haut-Uele 86.0%, Tshopo 82.3% and North Kivu 76.7%. The fall in listed contacts from 38,645 on 11 November to 25,864 on 14 November came from one province and has reversed: Ituri listed 16,447 contacts on 11 November, then 14,368, 11,510 and 5,298 on the following days, and 16,222 again on 15 November, which the SitReps do not explain. The rates cover listed contacts only: Africa CDC's director general, Jean Kaseya, told Reuters on 15 November that more than 80% of new cases emerge outside contact lists, and WHO said on 12 November that more than 1,000 contacts were lost after the attack on Cantine-Aloya and that three confirmed patients cannot be found. Recoveries reached 3,109 on 15 November, with 1,681 people in isolation.
Six months in, officials read the curve differently. The joint statement of WHO, Africa CDC, UNICEF, UNFPA and WFP on 15 November says most early epicentres, among them Mongbwalu, Nyankunde, Nizi, Rwampara and Butembo, have been brought under control and that new cases in Bunia have halved. WHO's Director-General told member states on 11 November that transmission is slowing in some areas but that progress in some places must not be confused with control of the outbreak as a whole, Actualite.cd reported, and Kaseya says it is “still not under control”. The SitReps for 11 to 15 November partly bear this out: Nyankunde reported no case, Mongbwalu 6 and Rwampara 8, but Nizi added 14, 9 of them on 13 November, Bunia 29, and Butembo, without a case in its cumulative count from 11 to 14 November, 3 on 15 November. On 12 November the incident manager, Steve Ahuka, said Tshopo had gone more than 42 days without a case, Actualite.cd reported; N°178 had recorded two Tshopo cases on 8 November, and the province reported ten more from 12 to 15 November. Health minister Roger Kamba's reading of 6 November, that the focus had moved to North Kivu and that Ituri accounted for 37.1% of new cases, is not borne out either: Ituri took 153 of the 318 cases from 11 to 15 November, 48.1%.
WHO's DON625, published on 6 November with the 3 November cut, gives a three-week view the SitReps do not: 1,463 new confirmed cases in 21 days, 710 in Ituri, 640 in North Kivu, 77 in Haut-Uele, 31 in Tshopo and 5 in Nord-Ubangi. Fifty-one of the 67 affected zones reported at least one case in that time, and Beni, Bunia and Mandima reported the most cases and deaths. North Kivu led the last seven days with 232 cases. Of 512 deaths reported since 21 October, 335 occurred in communities and 177 in treatment centres, and WHO singles out young children among community deaths. WHO says some areas have seen a slight decline in cases while sustained, high-level transmission continues overall, and that it is revising its rapid risk assessment of 14 August, which rates the risk very high in DRC, high in neighbouring countries and low regionally and globally.
The death count still needs a caveat. SitRep N°169, for 30 October, printed 5,372 deaths nationally and 3,769 in Ituri after a data-harmonisation exercise on 29 October between INSP's data-management pillar and Ituri's provincial incident-management team, which dropped a line of 493 Ituri deaths not yet assigned to a health zone and redistributed cases and deaths among zones. SitRep N°170 went back to the earlier series, and N°171, N°173 and N°174 stay on it, with the 493 Ituri deaths still unassigned on 4 November. On that series the 30 October figure is 5,058, 314 fewer than N°169 printed; the INRB data mirror carries the same 5,058. WHO's DON625 of 6 November uses the later series too. Africa CDC's figures shared with AFP on 2 November, 5,376 deaths including 5,372 in DRC, carried the N°169 number; a Radio Okapi press review of 6 November now has Africa CDC's director-general citing nearly 5,200 deaths, which would put the agency on the later series as well, though EbolaIntel has not seen its own statement. EbolaIntel follows the newest SitRep and will move the headline if INSP adopts the harmonised series.
Geography
Eight DRC provinces and 68 of its 178 health zones have confirmed cases; Watsa, in Haut-Uele and home to the Kibali gold mine, joined on 11 November. Ituri holds 68.9% of cases, with Bunia (2,098) and Rwampara (1,233) the largest zones; North Kivu has 2,889 and the highest case-fatality ratio, 55.4%, and its Beni zone (894) passed Nizi on 15 November to rank third. Tshopo has reported ten cases since 12 November. Outside DRC, Uganda's outbreak ended in July, Kenya could be declared free of Ebola on 23 December, and Nigeria has cleared all 62 contacts of its imported case.
More on geography (6 paragraphs)Show less
Eight provinces and 68 of 178 health zones are in the count. Watsa, in Haut-Uele, became the 68th on 11 November, the first new zone since Yakoma on 28 October. The 15 November province table sums exactly to the national figure: Ituri 7,881 / 3,725 (including 493 deaths not yet assigned to a zone), North Kivu 2,889 / 1,601, Haut-Uele 526 / 225, Tshopo 108 / 35, Bas-Uele 13 / 4, Nord-Ubangi 10 / 1, South Kivu 3 / 1 and Sud-Ubangi 2 / 1, totalling 11,432 / 5,593. Ituri holds 68.9% of cumulative cases, but North Kivu took 29 of the 56 new cases on 15 November, 51.8%, and its case-fatality ratio, 55.4%, is above the national one. The health-zone ranking, from the 15 November table, reads Bunia 2,098 cumulative confirmed cases, Rwampara 1,233, Beni 894, Nizi 881 and Mongbwalu 739, then Katwa 697 and Mandima 635; Beni moved past Nizi with 14 cases on 15 November. From 11 to 15 November Ituri took 153 of 318 cases, North Kivu 128, Haut-Uele 27 and Tshopo 10. In Ituri, Mandima added 43 cases in five days, Bunia 29, Mangala 27, Nizi 14 and Mambasa 13 to reach 159.
Two fronts reopened in the north. Watsa entered the count on 11 November with two confirmed cases, both deaths in the community, and reached nine on 13 November; it reported no new case on 14 or 15 November. Haut-Uele has cases in eight of its 13 zones. Watsa is home to Kibali, one of Africa's largest gold mines: in a memo dated 12 November and seen by Reuters, Barrick furloughed employees and subcontractors whose presence is not essential after two Ebola deaths in a nearby community, confirmed by INRB, and said it was checking whether there were links to its workforce. N°185 reports community resistance to decontamination in Watsa, and at Nganya, in Durba, the Kibali mining town, more than 50 people drove off a response team and the Red Cross with stones and machetes and sabotaged their vehicle, Actualite.cd reported on 17 November. The outlet says the Polyclinique Bavière in Durba was closed by decree while 14 of its own staff, positive, are cared for inside, and that patients at the Julien Andavo hospital, also closed, refuse to leave while Durba's treatment centre is still being built; INSP's 15 November table counts nine confirmed cases in Watsa zone and no other newly affected zone in Haut-Uele, so the outlet's figure cannot be matched to the official count. In Tshopo, N°182 to N°185 record ten cases from 12 to 15 November, five in Kabondo, three in Makiso-Kisangani and one each in Bafwasende and Tshopo zone, taking the province to 108 cases and 35 deaths; case 100, admitted on 13 November, is a nine-day-old baby. The SitReps report threats against response teams in Bafwasende, Kabondo and Mangobo, and health officials in Ituri's Nia-Nia zone worry about patients arriving from Bafwasende, Radio Okapi reported on 16 November.
Inside North Kivu the weight sits in the Beni-Katwa-Butembo corridor, and Beni leads it. Beni added 55 cases and 37 deaths from 11 to 15 November, 14 of the cases on 15 November alone, and stands at 894 cases and 580 deaths, a case-fatality ratio of 64.9%, now the third-largest zone in DRC; Médecins Sans Frontières said on 12 November that nearly three quarters of Ebola patients in the Beni zone were infected in a health facility. Oicha added 20 cases to reach 131, Mutwanga 10, Kalunguta 9, Katwa 9 and Masereka 6; Butembo, without a case in its cumulative count from 11 to 14 November, added 3 on 15 November. In Lubero territory, the Kirumba reference health centre in the Kayna zone closed for 21 days from 13 November after two confirmed cases were registered there since 6 November, Actualite.cd reported; the SitRep table still lists Kayna at 3 cases. North Kivu cared for 514 patients on 15 November, 125 of them confirmed: its treatment and transit centres held 343, 79% of 434 beds, with suspect wards 97% full, and 171 more were in facilities outside them.
Kenya's cluster has closed at nine cases and two deaths, with no new confirmed infection since 19 October. The index patient, a Kenyan citizen who had been living in DRC, flew to Nairobi via Kampala on 3 October and died on 5 October; all eight later cases were contacts already in quarantine, four family members and four health workers, and a 65-year-old relative died on 23 October. The other seven recovered. Five were discharged on 3 November and a sixth on 6 November, and on 11 November Health Cabinet Secretary Aden Duale announced that the last patient had been discharged and the final 11 contacts released after 21 days of monitoring, leaving no patient in care and no one in quarantine. Of 135 contacts identified since the first case, eight became cases and nine left Kenya, WHO's DON625 says. The 42-day countdown starts on 12 November, and Kenya could be declared free of Ebola on 23 December if no new infection is recorded, The Standard reported; Africa CDC's director general, Jean Kaseya, called the last discharge an important milestone, Xinhua reported. On 30 October Saudi Arabia suspended its citizens' travel to Kenya, halted visas for travellers from Kenya and barred entry to anyone who had been there in the previous 21 days; Duale said Kenya needs “support and collaboration, not condemnation”, the ministry has asked Saudi Arabia and Kuwait for the public-health justification for their measures, and Africa CDC called for the restrictions to be lifted.
Nigeria's imported case has recovered, and its contacts have been cleared. The patient, a woman in Abuja with recent travel history to Uganda, developed symptoms on 7 October and tested positive on 20 October, according to WHO's regional office; flown to Switzerland with her husband, a Swiss diplomat, on 26 October, she has since been discharged from hospital in Geneva, CIDRAP and Al Jazeera report. The Nigeria Centre for Disease Control said on 13 November that all 62 contacts had completed 21 days of monitoring without falling ill; 13 reported fever or other non-specific symptoms and tested negative, as did seven alerts in five states over three weeks. The NCDC added that finishing contact follow-up does not by itself end the outbreak, which under WHO practice takes 42 days. EbolaIntel keeps the case outside the headline.
Travel measures tightened in the last week of October, against WHO advice, and on 4 November WHO's Director-General asked for them to be lifted. “We call on countries that have imposed travel restrictions to lift them,” Tedros told a briefing in Geneva, adding that “such restrictions punish countries for doing the right thing” and that they discourage transparency and harm the response. Uganda's health minister, Chris Baryomunsi, announced on 25 October that Ugandans returning from DRC must spend 21 days in quarantine at their own cost and that travellers with DRC travel history may no longer transit through Uganda, including on chartered flights; Uganda has had no confirmed case since its own outbreak ended. Saudi Arabia's measures against Kenya followed on 30 October. The United States keeps barring anyone who has been in DRC in the previous 21 days from boarding commercial flights to the country, and since 23:59 Eastern time on 3 November every passenger on an international flight to the US must attest to not having been in DRC in that period, according to CDC's situation page; citizens who have been only in Uganda or South Sudan must enter through designated airports for enhanced screening.
Response
Six months in, violence, distrust and unpaid work are the main brakes on the response. WHO has verified 81 attacks on health care since May; the attack on Cantine-Aloya killed 66 civilians, three of them health workers, and cost more than 1,000 contacts. In Durba, Haut-Uele, a crowd drove off a decontamination team with stones and machetes, Actualite.cd reported on 17 November. Treatment-centre staff in Butembo, Katwa and Musienene have been on strike since 12 November over pay, and MSF says the money pledged is not reaching the front line.
More on response (6 paragraphs)Show less
Distrust is spreading with the virus into new areas. At Nganya, in Durba, more than 50 people chased away a response team and the Red Cross who had come to decontaminate a bereaved family's home, stoning them, brandishing machetes and sabotaging their vehicle; no one was killed, according to first accounts gathered by Actualite.cd and published on 17 November. Residents told the outlet that nobody had explained what was being sprayed, where patients were taken or when Durba's treatment centre would be ready, and that the Julien Andavo hospital had been closed by decree without a prior infection-control assessment. SitRep N°185 reports community resistance to decontamination in Watsa, five patients escaping from care in Haut-Uele's Pawa zone and 20 patients without food in Mandima on 15 November. Four UN agencies warn that war and Ebola are deepening a food crisis that could reach more than 30 million people in DRC in early 2027, Radio Okapi reported on 16 November. Canada announced 2 million dollars for Ebola on 16 November, within a 24-million-dollar package for French-speaking Africa, and signed a cooperation agreement with Africa CDC.
Six months after the declaration on 15 May, WHO, Africa CDC, UNICEF, UNFPA and WFP said in a joint statement on 15 November that the outbreak continues to expand despite significant progress. Diagnostic capacity has grown from two laboratories to more than two dozen, close to 2,000 beds are available in 104 treatment and transit centres, around 3,000 people have recovered, a quarter of them enrolled in the survivor programme, and almost 90% of registered deaths now receive a safe and dignified burial. But 400 to 500 cases are still reported a week, two thirds of confirmed deaths occur in the community, contact follow-up remains below target and delays in paying health workers slow the response; the agencies ask for funding through 2027. Africa CDC's Jean Kaseya told Reuters the same day that only 1.3 billion of the 2.9 billion dollars pledged had been released and called coordination between DRC and donors a collective failure. UNICEF counts 2,959 children confirmed and 1,737 dead as of 4 November: children are 28% of cases and 35% of deaths, and about 80% of child deaths occur outside treatment centres.
Insecurity remains the largest obstacle. WHO's regional emergencies director, Marie-Roseline Bélizaire, said at a press conference in Bunia on 12 November that WHO has verified 81 attacks on health facilities since the outbreak was declared, and that the armed attack on Cantine-Aloya the week before killed 66 civilians, three of them health workers, and saw three health facilities looted; more than 1,000 contacts were lost to follow-up and three confirmed cases cannot be found. The joint statement adds that the town was attacked again early on 11 November. The UN said on 13 November that in recent days the ADF had killed more people in villages of Ituri and North Kivu than Ebola had, and its senior Ebola response coordinator, Julien Harneis, called contact tracing where the group operates “a very hazardous idea”, CIDRAP reported. Families from the Baswagha-Madiwe area of Beni territory have been fleeing to Maboya since 14 November, and in Mambasa the ADF still hold dozens of people seized at the Mbembese mining site two weeks ago and demand 2,000 dollars for each, Radio Okapi reported.
Pay disputes have turned into open strikes. Staff of the treatment and transit centres and the infection-control supervisors in the Butembo, Katwa and Musienene zones have been on an unlimited strike since 12 November, demanding higher and fairer risk allowances and the legal minimum wage after four months of work without a formal contract, Actualite.cd reported; Butembo's civil society fears for patients' care. In Ituri, checkpoint and handwashing staff on the Komanda-Yedi axis stopped work the same day over months of arrears; IOM, which hired them, says payments are under way on the Bunia, Aru, Mahagi and Nia-Nia axes. Staff of the Kasenyi treatment centre remain on strike, and in Mandima 13 to 16 patients a day went without food from 11 to 13 November. MSF said on 12 November that despite hundreds of millions of dollars mobilised, health workers go unpaid, ambulances stand idle for lack of fuel and community workers lack phones or internet to send alerts; its international president, Javid Abdelmoneim, said many frontline health workers still face the virus empty-handed and unpaid. Health minister Roger Kamba told the National Assembly that partners' money is managed by the agencies, not the government, and that the United States had given him the list of agencies that received its 438 million dollars.
Unsafe practices and resistance persist. In Ituri's Mangala zone, families spray the bodies of Ebola victims with petrol in the false belief that it kills the virus and have gone back to washing bodies, the zone's chief medical officer said on 11 November; its Mandje health area recorded 24 suspected cases in a single day and about 25 confirmed in a week, Radio Okapi reported. On 14 November, 23 safe burials in Ituri failed or were refused, Bas-Uele's burial teams handled none of four community deaths reported that day, a burial in Isiro failed over community resistance, and a patient who had escaped in Rungu was returned to a makeshift treatment centre, SitRep N°184 says. Ituri's provincial health authorities said on 16 November that positive cases are falling in several zones, Mambasa among them, but that resistance at the PK 47 and PK 51 mining sites still hampers surveillance.
Insecurity is now costing the response its contacts. WHO's regional emergencies director, Roselyne Bélizaire, told DW on 11 November that more than 10,000 contacts in this outbreak cannot currently be followed. In Mabalako, 1,005 of 1,621 contacts, 62%, were lost to follow-up after the attacks of 5 and 6 November, and after the raid on Aloya, where more than 40 people were killed in a single night, displaced residents are hard to trace; SitRep N°178 counts 44 bodies after the ADF attacks in Mabalako, against the earlier counts of 33 and 35 for Cantine-Aloya. WHO, in a statement reported by Radio Okapi on 10 November, said all its staff in the area were safe and warned that violence only makes it easier for the virus to spread. In Ituri, fighting near the Plaine Savo displacement site in Fataki wounded at least five civilians on 8 November and halted a humanitarian assessment mission, and the UN's acting humanitarian coordinator, Alain Akpadji, called for safe access for health workers. SitRep N°179 reports that the Mabitane health centre in Ituri's Lolwa zone was set on fire.
WHO classification
PHEIC declared 17 May 2026 and continued at the second IHR Emergency Committee review. The statement of 24 August records the meeting of 18 August and carries the Director-General's updated temporary recommendations, the instrument that governs an ongoing determination; nothing in it terminates the PHEIC. In the updated set only the DRC remains classified as a state with community transmission, while Uganda moves to the neighbouring-country group after its 28 July end declaration, at a risk level WHO assesses as high against very high for DRC.
More on who classification (1 paragraph)Show less
The Committee first cited urban spread, healthcare-worker infections and the lack of approved countermeasures for this strain. A new section on social measures instructs DRC to postpone mass gatherings in transmission zones, reduce crowding in bars and nightclubs, limit motorbikes to one passenger, open schools safely, run 24/7 health checkpoints on roads out of affected areas, and place Bundibugyo surveillance aboard vessels navigating inland waterways toward major urban centres including Kinshasa.
Countermeasures
No approved vaccine or therapeutic targets Bundibugyo virus: Ervebo, Zabdeno plus Mvabea, Inmazeb and Ebanga cover Zaire ebolavirus only. Ervebo is tested for cross-protection in the Tumaini trial and given to frontline workers under a compassionate protocol; WHO's vaccine advisers meet on 17 November on MSF's call for wider use. ChAdOx1 BDBV and mRNA-1469 are cleared to join Tumaini. Gilead has licensed three generic makers to produce obeldesivir, tested as post-exposure prophylaxis, if the trial supports it.
More on countermeasures (6 paragraphs)Show less
No approved vaccine or therapeutic targets Bundibugyo virus. All approved products, Ervebo, Zabdeno plus Mvabea, Inmazeb and Ebanga, cover Zaire ebolavirus only. On 4 November WHO said its expert advisers had recommended adding the first two Bundibugyo-specific vaccine candidates, Oxford's ChAdOx1 BDBV, made with the Serum Institute of India, and Moderna's mRNA-1469, to the Tumaini trial in DRC; they enter once national approvals are in place, and WHO says it will be the first time vaccines designed against this virus are tested during an outbreak of it. Tumaini, a Phase 2/3 ring-vaccination trial led by INRB with CEPI funding, opened in Bunia on 23 October with Ervebo to test for cross-protection and has four rings in place; results are expected in early 2027. Maftivimab, one of Inmazeb's three antibodies, will soon join the PARTNERS treatment trial. Outside the trials, Ervebo is given under a compassionate protocol in Ituri, Haut-Uele, Bas-Uele and Tshopo; North Kivu used its last doses on 8 November, and Nord-Ubangi has yet to report any vaccination. WHO states it is not known whether Ervebo protects against Bundibugyo virus in humans.
Frontline-worker vaccination with Ervebo continues where doses remain. North Kivu, which ran out on 8 November, has received new doses, 3,600 in all, and vaccinated 3,352 people by 14 November, 3,235 frontline workers and 117 contacts, in five zones; 247 doses were left and the province asked urgently for 10,000 more, SitRep N°184 says. Ituri counts 3,930 people vaccinated (N°182), Haut-Uele 1,809, 72% of the frontline workers it targets, with deployment under way to Gombari, and Bas-Uele 2,211, with 195 doses at risk of expiring. Tshopo reports 13,655 people vaccinated, 91.3% of its target, but only 23 doses left on 11 November and a request for 500 more as vaccination continues around new cases. In Tshopo, 67 confirmed patients have received an investigational treatment, of whom 48 recovered and 17 died, and 612 people post-exposure prophylaxis, N°179 says; without a comparison group these figures say nothing about efficacy. This is an emergency deployment wrapped around a trial, not a licence extension, and no efficacy data against this strain exists yet.
Médecins Sans Frontières asked on 9 November for wider use of Ervebo while Bundibugyo-specific vaccines are developed. A larger release of doses from the stockpile depends on WHO's Strategic Advisory Group of Experts on Immunization, which meets on 17 November; DRC asked the International Coordinating Group in August for 500,000 doses and 70,000 were released. MSF and its research centre Epicentre report encouraging signs among responders vaccinated with Ervebo in earlier outbreaks, fewer confirmed cases and indications of lower mortality, but these are field observations, not trial results: whether Ervebo protects against Bundibugyo virus is what Tumaini and MSF's BRAVO study are meant to establish.
On 16 November Gilead signed royalty-free voluntary licences with three generic manufacturers, Dr. Reddy's Laboratories, Eva Pharma and Ferozsons Laboratories, for obeldesivir as post-exposure prophylaxis against Bundibugyo virus disease. They cover 127 mainly low- and lower-middle-income countries, including every African country that has reported cases in this outbreak, and allow manufacture and supply only if clinical data and regulatory approvals support it; technology transfer is under way. Obeldesivir is approved for no indication in any country. It is being tested in EBO-PEP, a Phase 3 randomised, placebo-controlled trial run by ALIMA with INRB and ANRS MIE in Ituri. Gilead is also extending its remdesivir licences to filovirus disease, pending results of WHO's PARTNERS trial, and says it has donated more than 38,000 vials of remdesivir to DRC, Uganda and Kenya for compassionate use. Neither drug is approved against Bundibugyo virus.
WHO's Technical Advisory Group on Candidate Vaccines Prioritization recommended both Bundibugyo-specific candidates for further clinical evaluation on the basis of preclinical and early clinical evidence, and the companies were told on 2 November. Tumaini is led by DRC's INRB with the University of Antwerp, WHO, Epicentre, Médecins Sans Frontières, the Institute of Tropical Medicine in Antwerp and Africa CDC, and enrols contacts of people with confirmed Bundibugyo virus disease. “Vaccines alone will not end this outbreak, but they could become a powerful new tool for bringing it under control,” the Director-General said. On treatments, WHO said maftivimab will soon be added to the PARTNERS trial, which compares MBP134, remdesivir and the two combined against standard care, that a post-exposure prophylaxis study of obeldesivir is under way, and that initial findings from the treatment trials are expected in the coming months.
Two Bundibugyo-specific vaccine candidates are in early human trials and moving into Uganda: the Oxford ChAdOx1 BDBV candidate began a Phase I study in Masaka City on 6 October, and Moderna's mRNA-1469, in a Phase 1 trial in Canada since 3 August, received ethical approval for a Phase Ib trial in Uganda on 7 October, according to Africa CDC. These trials measure safety and immune response, not protection. WHO's immunisation director, Kate O'Brien, said on 13 October that the Oxford candidate could join Tumaini quickly if its early data are positive.
Aid cuts
The response has unfolded against deep cuts to global health aid. Reporting on 6 July by CNBC, and separately by PBS NewsHour and the Harvard T.H. Chan School of Public Health, quotes infectious-disease specialists and virologists who say the dismantling of USAID in 2025 has demonstrably worsened the outbreak. USAID had trained health workers to recognise Ebola, supplied testing kits and personal protective equipment, and helped move samples to laboratories; its withdrawal slowed contact tracing, eroded community trust, and left existing medical supplies harder to move into the worst-hit parts of Ituri.
More on aid cuts (1 paragraph)Show less
A Rockefeller Foundation and Echelon Insights poll published on 7 July, fielded 12-16 June among 2,022 US voters, found that 75% of Americans support restoring US disease-prevention aid for the DRC Ebola outbreak and 90% support funding overseas disease-prevention programmes generally. The State Department announcement of 5 August, which takes total direct US assistance for this outbreak past US$512 million, is the largest single reversal of that trend the outbreak has produced, though it arrives through a different channel than the dismantled agency and alongside entry restrictions that treatment providers say cost them staff.